Industry Payments to Physicians by Competing Manufacturers Within Novel Therapeutic Classes.
作者信息
Sun Q Wilton, Ross Joseph S
机构信息
Yale School of Medicine, New Haven, Connecticut.
Section of General Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
出版信息
JAMA. 2024 Nov 7;332(24):2111-3. doi: 10.1001/jama.2024.20842.
Abstract
摘要
相似文献
1
Industry Payments to Physicians by Competing Manufacturers Within Novel Therapeutic Classes.新型治疗类别中竞争厂商向医生支付的行业款项。
JAMA. 2024 Nov 7;332(24):2111-3. doi: 10.1001/jama.2024.20842.
2
Association Between Industry Payments to Physicians and Device Selection in ICD Implantation.医生收受行业款项与 ICD 植入装置选择的关联。
JAMA. 2020 Nov 3;324(17):1755-1764. doi: 10.1001/jama.2020.17436.
3
Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: cross sectional ecological study.制药厂商向医生支付款项与地区处方之间的关联：横断面生态研究。
BMJ. 2016 Aug 18;354:i4189. doi: 10.1136/bmj.i4189.
4
Exploring the Industry-Dermatologist Financial Relationship: Insight From the Open Payment Data.探索行业-皮肤科医生的财务关系：来自公开支付数据的洞察。
JAMA Dermatol. 2016 Dec 1;152(12):1307-1313. doi: 10.1001/jamadermatol.2016.3037.
5
Industry payments to spine surgeons from 2014 to 2019: trends and comparison of payments to spine surgeons versus all physicians.2014 年至 2019 年脊柱外科医生的行业支付情况：脊柱外科医生与所有医生支付情况的趋势和比较。
Spine J. 2022 Jun;22(6):910-920. doi: 10.1016/j.spinee.2022.01.008. Epub 2022 Jan 15.
6
Industry Payment to Vascular Neurologists: A 6-Year Analysis of the Open Payments Program From 2013 Through 2018.行业向血管神经科医生支付款项：2013 年至 2018 年开放支付计划六年分析。
Stroke. 2020 Apr;51(4):1339-1343. doi: 10.1161/STROKEAHA.119.027967. Epub 2020 Feb 12.
7
Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data.医药行业支付与高成本药物处方之间的关联：一项使用公开支付数据和医疗保险D部分数据的观察性研究。
BMC Health Serv Res. 2018 Apr 2;18(1):236. doi: 10.1186/s12913-018-3043-8.
8
Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.制药业赞助的餐饮与医疗保险受益人的医师处方模式
JAMA Intern Med. 2016 Aug 1;176(8):1114-1122. doi: 10.1001/jamainternmed.2016.2765.
9
Industry Payments to Nephrologists in the United States.美国行业向肾脏病学家的付款。
Cureus. 2021 Aug 10;13(8):e17057. doi: 10.7759/cureus.17057. eCollection 2021 Aug.
10
Financial Transactions from Manufacturers to Otolaryngologists in 2018.2018年制造商与耳鼻喉科医生之间的财务交易。
Laryngoscope. 2021 Feb;131(2):E388-E394. doi: 10.1002/lary.28935. Epub 2020 Jul 23.
引用本文的文献
1
Endovascular therapy vs. conventional medical treatment for symptomatic intracranial atherosclerotic stenosis: an updated meta-analysis of randomized controlled trials.血管内治疗与传统药物治疗对症状性颅内动脉粥样硬化狭窄的疗效比较：随机对照试验的最新荟萃分析
Neuroradiology. 2025 Aug 20. doi: 10.1007/s00234-025-03736-5.
本文引用的文献
1
Tackling the excesses of pharmaceutical marketing and promotion.应对药品营销与推广中的过度行为。
BMJ. 2024 May 21;385:e076797. doi: 10.1136/bmj-2023-076797.
2
Industry Payments to US Physicians by Specialty and Product Type.按专业和产品类型划分的行业对美国医生的付款。
JAMA. 2024 Apr 16;331(15):1325-1327. doi: 10.1001/jama.2024.1989.
3
PD-1 and PD-L1: architects of immune symphony and immunotherapy breakthroughs in cancer treatment.PD-1 和 PD-L1：免疫交响乐的建筑师和癌症治疗免疫疗法突破的推动者。
Front Immunol. 2023 Dec 1;14:1296341. doi: 10.3389/fimmu.2023.1296341. eCollection 2023.
4
Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis.针对银屑病中 IL-23 和 IL-17 通路的治疗方法。
Lancet. 2021 Feb 20;397(10275):754-766. doi: 10.1016/S0140-6736(21)00184-7. Epub 2021 Jan 27.
5
Are Financial Payments From the Pharmaceutical Industry Associated With Physician Prescribing? : A Systematic Review.制药业的财务支付与医生处方是否有关？：系统评价。
Ann Intern Med. 2021 Mar;174(3):353-361. doi: 10.7326/M20-5665. Epub 2020 Nov 24.
6
Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus: A Scientific Statement From the American Heart Association.《2 型糖尿病患者稳定型冠状动脉疾病的临床管理：美国心脏协会的科学声明》。
Circulation. 2020 May 12;141(19):e779-e806. doi: 10.1161/CIR.0000000000000766. Epub 2020 Apr 13.
Zotero 插件